Seroprevalence of pandemic h1n1 antibody among health care workers in hong kong following receipt of monovalent 2009 h1n1 influenza vaccine

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Zhou, Ying ^a   Ng, Diane M W ^a   Seto, Wing Hong ^b   Ip, Dennis K M ^a   Kwok, Henry K H ^b   Ma, Edward S K ^a   Ng, Sophia ^a   Lau, Lincoln L H ^a   Peiris, J S Malik ^a,c   Cowling, Benjamin J ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b HOSPITAL AUTHORITY   (Hong Kong)

^c HKU PASTEUR RESEARCH CENTRE   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA A VIRUS ANTIBODY; INFLUENZA VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

2009 H1N1 INFLUENZA; ADULT; AGE; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG EFFICACY; FEMALE; HEALTH CARE PERSONNEL; HEMAGGLUTINATION INHIBITION TEST; HONG KONG; HUMAN; IMMUNOGENICITY; INFLUENZA VIRUS A H1N1; MALE; NORMAL HUMAN; SEASONAL INFLUENZA; SEROPREVALENCE; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VIRUS NEUTRALIZATION; BLOOD; EPIDEMIOLOGY; IMMUNOLOGY; INFLUENZA; MIDDLE AGED; OCCUPATIONAL EXPOSURE; PANDEMIC; SERODIAGNOSIS; VACCINATION; VIROLOGY;

ADULT; ANTIBODIES, VIRAL; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH PERSONNEL; HEMAGGLUTINATION INHIBITION TESTS; HONG KONG; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; NEUTRALIZATION TESTS; OCCUPATIONAL EXPOSURE; PANDEMICS; SEROEPIDEMIOLOGIC STUDIES; VACCINATION; YOUNG ADULT;

EID: 80755159561     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027169     Document Type: Article

References (46)

1. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, et al. (2009) Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360: 2605-2615.
2. Cowling BJ, Lau MSY, Ho LM, Chuang SK, Tsang T, et al. (2010) The Effective Reproduction Number of Pandemic Influenza: Prospective Estimation. Epidemiology 21: 842-846.
3. Seto W-H, Cowling BJ, Lam H-S, Ching PTY, To M-L, et al. (2011) Clinical and Non-Clinical Healthcare Workers Faced a Similar Risk of Acquiring 2009 Pandemic H1N1 Infection. Clin Infect Dis 53: 280-283.
4. Zhou Y, Ng DMW, Seto W-H, Ip DKM, Kwok HKH, et al. (2011) Seroprevalence of antibody to pandemic (H1N1) 2009 among health care workers after the first wave in Hong Kong. J Hosp Infect 78: 308-311.
5. Greenberg ME, Lai MH, Hartel GF, Wichems CH, Gittleson C, et al. (2009) Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med 361: 2405-2413.
6. Zhu F, Wang H, Fang H, Yang J, Lin X, et al. (2009) A novel influenza A (H1N1) vaccine in various age groups. N Engl J Med 361: 2414-2423.
7. Clark T, Pareek M, Hoschler K, Dillon H, Nicholson K, et al. (2009) Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. N Engl J Med 361: 2424-2435.
8. Liang X, Wang H, Wang J, Fang H, Wu J, et al. (2009) Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 375: 56-66.
9. Vajo Z, Tamas F, Sinka L, Jankovics I, (2009) Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomised controlled trial. Lancet 375: 49-55.
10. Plennevaux E, Sheldon E, Blatter M, Reeves-Hoche M, Denis M, (2009) Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials. Lancet 375: 41-48.
11. Liao Q, Cowling BJ, Lam WW, Fielding R, (2011) Factors affecting intention to receive and self-reported receipt of 2009 pandemic (H1N1) vaccine in Hong Kong: a longitudinal study. PLoS ONE 6: e17713.
12. Wu J, Ma E, Lee C, (2010) The infection attack rate and severity of 2009 pandemic influenza (H1N1) in Hong Kong. Clin Infect Dis 51: 1184-1191.
13. Cowling BJ, Chan KH, Fang VJ, Lau LL, So HC, et al. (2010) Comparative epidemiology of pandemic and seasonal influenza A in households. N Engl J Med 362: 2175-2184.
14. Department of Health,The Government of Hong Kong SAR, China (2009) Statistics on human swine influenza vaccinations. Available: http://www.dh.gov.hk/english/press/2009/press_2009.html. Accessed 2011 Feb 21.
15. Department of Health,The Government of Hong Kong SAR, China (2010) Statistics on human swine influenza vaccinations. Available: http://www.dh.gov.hk/english/press/2010/press_2010.html. Accessed 2011 Feb 21.
16. Sterne JA, White IR, Carlin JB, Spratt M, Royston P, et al. (2009) Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 338: b2393.
17. Ng S, Wu P, Nishiura H, Ip D, Lee E, et al. (2011) An analysis of national target groups for monovalent 2009 pandemic influenza vaccine and trivalent seasonal influenza vaccines in 2009-10 and 2010-11. BMC Infect Dis 11: 230.
18. Poland G, Tosh P, Jacobson R, (2005) Requiring influenza vaccination for health care workers: seven truths we must accept. Vaccine 23: 2251-2255.
19. Maltezou HC, Maragos A, Katerelos P, Paisi A, Karageorgou K, et al. (2008) Influenza vaccination acceptance among health-care workers: a nationwide survey. Vaccine 26: 1408-1410.
20. Bull AL, Bennett N, Pitcher HC, Russo PL, Richards MJ, (2007) Influenza vaccine coverage among health care workers in Victorian public hospitals. Med J Aust 186: 185-186.
21. Walker FJ, Singleton JA, Lu P, Wooten KG, Strikas RA, (2006) Influenza vaccination of healthcare workers in the United States, 1989-2002. Infect Control Hosp Epidemiol 27: 257-265.
22. de Juanes J, Garcia de Codes A, Arrazola M, Jaen F, Sanz M, et al. (2007) Influenza vaccination coverage among hospital personnel over three consecutive vaccination campaigns (2001-2002 to 2003-2004). Vaccine 25: 201-204.
23. Song JY, Park CW, Jeong HW, Cheong HJ, Kim WJ, et al. (2006) Effect of a hospital campaign for influenza vaccination of healthcare workers. Infect Control Hosp Epidemiol 27: 612-617.
24. Shroufi A, Copping J, Musonda P, Vivancos R, Langden V, et al. (2009) Influenza vaccine uptake among staff in care homes in Nottinghamshire: A random cluster sample survey. Public Health 123: 645-649.
25. Isaacs D, Leask J, (2008) Should influenza immunisation be mandatory for healthcare workers? No BMJ 337: a2140.
26. Tilburt JC, Mueller PS, Ottenberg AL, Poland GA, Koenig BA, (2008) Facing the challenges of influenza in healthcare settings: the ethical rationale for mandatory seasonal influenza vaccination and its implications for future pandemics. Vaccine 26: D27-D30.
27. Helms CM, Polgreen PM, (2008) Should influenza immunisation be mandatory for healthcare workers? Yes BMJ 337: a2142.
28. Al-Khayatt R, Jennings R, Potter C, (1984) Interpretation of responses and protective levels of antibody against attenuated influenza A viruses using single radial haemolysis. J Hyg (Lond) 93: 301-312.
29. Van der Vliet D, Pepin S, Lambert M, Fauchoux N, Donazzolo Y, et al. (2010) Similar immunogenicity of the A/H1N1 2009 pandemic influenza strain when used as a monovalent or a trivalent vaccine. Hum Vaccin 6: 34-39.
30. Igari H, Segawa S, Watanabe A, Suzuki A, Watanabe M, et al. (2010) Immunogenicity of a monovalent pandemic influenza A H1N1 vaccine in health care workers of a university hospital in Japan. Microbiol Immunol 54: 618-624.
31. Hung IFN, To KKW, Lee CK, Lin CK, Chan J, et al. (2010) Effect of Clinical and Virological Parameters on the Level of Neutralizing Antibody against Pandemic Influenza A Virus H1N1 2009. Clin Infect Dis 51: 274-279.
32. Ohfuji S, Fukushima W, Deguchi M, Kawabata K, Yoshida H, et al. (2011) Immunogenicity of a Monovalent 2009 Influenza A (H1N1) Vaccine Among Pregnant Women: Lowered Antibody Response by Prior Seasonal Vaccination. J Infect Dis 203: 1301.
33. Nolan T, McVernon J, Skeljo M, Richmond P, Wadia U, et al. (2010) Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial. JAMA 303: 37-46.
34. Choi YS, Baek YH, Kang W, Nam SJ, Lee J, et al. (2011) Reduced Antibody Responses to the Pandemic (H1N1) 2009 Vaccine after Recent Seasonal Influenza Vaccination. Clin Vaccine Immunol 18: 1519-1523.
35. Uno S, Kimachi K, Kei J, Miyazaki K, Oohama A, et al. (2011) Effect of prior vaccination with a seasonal trivalent influenza vaccine on the antibody response to the influenza pandemic H1N1 2009 vaccine: randomized controlled trial. Microbiol Immunol doi:10.1111/j.1348-0421.2011.00381.x.
36. Wu J, Zhong X, Li CK, Zhou J, Lu M, et al. (2011) Optimal vaccination strategies for 2009 pandemic H1N1 and seasonal influenza vaccines in humans. Vaccine 29: 1009-1016.
37. Gross PA, Sperber SJ, Donabedian A, Dran S, Morchel G, et al. (1999) Paradoxical response to a novel influenza virus vaccine strain: the effect of prior immunization. Vaccine 17: 2284-2289.
38. Roman F, Vaman T, Kafeja F, Hanon E, Van Damme P, (2010) AS03 (A)-Adjuvanted Influenza A (H1N1) 2009 Vaccine for Adults up to 85 Years of Age. Clin Infect Dis 51: 668-677.
39. Nolan T, Richmond PC, Formica NT, Höschler K, Skeljo MV, et al. (2008) Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children. Vaccine 26: 6383-6391.
40. Smith DJ, Forrest S, Ackley DH, Perelson AS, (1999) Variable efficacy of repeated annual influenza vaccination. Proc Natl Acad Sci U S A 96: 14001-14006.
41. Iorio AM, Camilloni B, Basileo M, Neri M, Lepri E, et al. (2007) Effects of repeated annual influenza vaccination on antibody responses against unchanged vaccine antigens in elderly frail institutionalized volunteers. Gerontology 53: 411-418.
42. Hardelid P, Andrews N, Hoschler K, Stanford E, Baguelin M, et al. (2010) Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1. Health Technology Assessment 14: 115-192.
43. Chan KH, To KKW, Hung IFN, Zhang AJX, Chan JFW, et al. (2011) Differences in Antibody Responses of Individuals with Natural Infection and Those Vaccinated against Pandemic H1N1 2009 Influenza. Clin Vaccine Immunol 18: 867.
44. Brydak LB, Macha a M, My liwska J, My liwski A, Trzonkowski P, (2003) Immune response to influenza vaccination in an elderly population. J Clin Immunol 23: 214-222.
45. Künzel W, Glathe H, Engelmann H, Van Hoecke C, (1996) Kinetics of humoral antibody response to trivalent inactivated split influenza vaccine in subjects previously vaccinated or vaccinated for the first time. Vaccine 14: 1108-1110.
46. Liu W, de Vlas SJ, Tang F, Ma MJ, Wei MT, et al. (2010) Clinical and immunological characteristics of patients with 2009 pandemic influenza A (H1N1) virus infection after vaccination. Clin Infect Dis 51: 1028.